West African genes lower the risk of obesity in men, suggests study

June 01, 2016

The obesity epidemic affects women and men of every ethnic group in the United States, but strong gender and racial disparities in the risk of overweight and obesity exist. African American women are currently more at risk than any other group in the United States: 82.1% of African American women are overweight or obese (defined as having a BMI of 25 or higher), compared to 76.2% of Hispanic women and 64.6% of Caucasian women, according to the 2011-2012 National Health and Nutrition Examination Survey (NHANES) [1]. Socioeconomic factors, such as inequalities in access to healthcare, healthy food, and safe places to exercise, are known to be important causes of these and other racial disparities in health characteristics.

In contrast, "only" 69.1% of African American men are overweight or obese - a percentage that is still alarmingly high in absolute terms, but lower than the percentages for Caucasian men (73.2%), and Hispanic men (77.9%), according to the NHANES data. A similar pattern has been reported for type-2 diabetes, a disease strongly associated with overweight and obesity: according to a 2007 study in The American Journal of Public Health [2], the incidence of diabetes is higher among African American women (24.5%) than among Caucasian women (20.7%), but lower among African American men (16.7%) than among Caucasian men (19.6%).

Why do African American men have a relatively low risk of overweight, obesity, and diabetes, despite facing many of the same socioeconomic disadvantages as African American women? A new study in the open-access journal Frontiers in Genetics [3] suggests that the cause may be partly genetic.

"Here we show that West-African genetic ancestry may afford protection against central adiposity in African American men, but not in African American women," says Yann Klimentidis, Assistant Professor at the Epidemiology and Biostatistics Department of the University of Arizona, the study's lead author.

Central adiposity ("belly fat"), the build-up of excess fat under the skin of the lower torso and around the internal organs, is a strong risk factor for obesity and diabetes, as well as for high blood pressure, high blood sugar, disease of the heart, liver, and pancreas, and some cancers.

In the new study, Klimentidis and colleagues analyze genetic data from 4,425 volunteers, all healthy African American women and men between the ages of 45 and 85. These data had been collected in the course of two prospective studies sponsored by the National Heart Lung and Blood Institute of the NIH: the Atherosclerosis Risk in Communities Study (ARIC) [4] and the Multi-Ethnic Study of Atherosclerosis (MESA) [5].

Klimentidis et al. focused on approximately 3,500 nucleotides ("letters" in the genome) that often differ between people from West Africa and Europe. In this way, they could estimate the degree of West African genetic ancestry - the fraction of the genome inherited from West African ancestors - for each participant in the study. A 2015 study in The American Journal of Human Genetics [6] has shown that this fraction varies considerably among African Americans, due to differences in genetic contributions from ancestors from other ethnic groups, especially Europeans and Native Americans.

The new results show that the Waist Circumference and Waist-Hip Ratio tends to be lower in African American men with a high degree of West African genetic ancestry, indicating that they have less central adiposity than African American men with a lower degree of West African genetic ancestry. In contrast, there was no association between Waist Circumference and Waist-Hip Ratio and the degree of West African genetic ancestry in African American women.

The researchers conclude that the gene pool of the African American population contains one or more gene variants - originally inherited from West African ancestors -- that give partial protection against central adiposity, but only when present in men. Further research is needed to identify these gene variants and the physiological mechanisms through which they operate, to help prevent and treat central obesity.

"There are still many unanswered questions, including: What are the specific genes that afford protection against central adiposity in men of West African ancestry, or conversely, What are the genes that predispose individuals of other ancestries to greater central adiposity? What cultural, socio-economic, or other factors might explain the lack of protection in African American women?" says Klimentidis.

"The reasons for group differences in multifactorial traits like obesity remain difficult to understand, especially when simplistic explanations do not easily explain complex patterns, like group differences which are not constant across sexes. We believe these new analyses begin to shed light on the factors underpinning the some ethnic disparities in obesity," says David Allison, Distinguished Professor of Public Health and Director of the Nutrition Obesity Research Center at University of Alabama at Birmingham, a coauthor on the study.

[1] http://jama.jamanetwork.com/article.aspx?articleid=1832542

[2] http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2089102/

[3] http://journal.frontiersin.org/article/10.3389/fgene.2016.00089/full

[4] http://aricnews.net/

[5] https://www.mesa-nhlbi.org/

[6] http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2089102/


Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.